Bullish case
$36 to $44
More likely if the Fertitta deal closes or a rival bid emerges near the rumored $86/share level, or if the company delivers faster-than-expected debt reduction, EBITDA grows above $3.8 billion, and interest costs decline as debt is repaid or refinanced at lower rates.